Comparative study of intravenous medication and pelvic perfusion on patients with gynecological pelvic inflammatory disease

Xiaoli Zhang, Hui Liu, Xiuqin Wang
In: Zhongguo jiceng yiyao · 2013 · vol. 20(21) , pp. 3234–3235 · doi:10.3760/cma.j.issn.1008-6706.2013.21.015 · W3030247404
RCT OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-07 ⓘ

Pelvic perfusion therapy in 120 patients with pelvic inflammatory disease showed significantly higher efficacy and lower adverse reactions compared to standard intravenous medication.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-21 · read from full text ⓘ

This study compared the clinical efficacy of intravenous medication versus pelvic perfusion in treating 120 patients with acute and chronic gynecological pelvic inflammatory disease. The results indicated that pelvic perfusion yielded significantly higher rates of obvious and total effectiveness compared to intravenous therapy, alongside a statistically lower incidence of adverse reactions. These findings suggest that pelvic perfusion is a superior treatment modality for improving symptoms and reducing side effects in this patient population. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Objective To investigate the effects of intravenous medication and pelvic perfusion in the treatment of gynecological acute and chronic pelvic inflammatory disease.Methods 120 cases with pelvic inflammatory disease were randomly divided into two groups.The control group(60 cases) received intravenous drugs.The observation group(60 cases) were given pelvic infusion therapy.The treatment efficacy of the two groups was compared after treatment for 14 days.Results The obvious effective rate of the observation group was 80.00％,which was significantly higher than 50.00％ in the control group(x2 =11.58,P ＜ 0.05).The total effective rate in the observation group was 90.00％,which was significantly higher than 68.33％ in the the control group(x2 =13.72,P ＜ 0.05).The incidence rate of adverse reactions in the control group was 38.33％,that in the observation group was 20.00％,the difference between the two groups was significant(x2 =4.18,P ＜ 0.05).Conclusion Pelvic perfusion therapy can improve the clinical efficacy of pelvic inflammatory disease,improve the symptoms of patients,reduce side effects,which is worthy of clinical application. Key words: Pelvic inflammatory disease ;  Perfusion;  Route of administration
Full text 1,664 characters · extracted from oa-doi-fallback · click to expand
静脉给药与盆腔灌注治疗盆腔炎效果比较 Comparative study of intravenous medication and pelvic perfusion on patients with gynecological pelvic inflammatory disease 摘要目的 探讨静脉给药与盆腔灌注治疗急慢性盆腔炎的临床效果.方法 对120例盆腔炎患者采用抽签法随机分组,对照组60例给予静脉药物治疗,观察组60例给予盆腔灌注治疗.治疗14 d后对两组进行疗效比较.结果 观察组显效率为80.00％,显著高于对照组的50.00％(x2=11.58,P＜0.05)；观察组总有效率为90.00％,明显高于对照组的68.33％(x2=13.72,P＜0.05).对照组不良反应发生率38.33％,观察组不良反应发生率20.00％,两组差异有统计学意义(x2=4.18,P＜0.05).结论 盆腔灌注治疗提高了盆腔炎患者的临床疗效,可改善患者症状,减轻副作用,值得临床推广应用. 更多相关知识 abstractsObjective To investigate the effects of intravenous medication and pelvic perfusion in the treatment of gynecological acute and chronic pelvic inflammatory disease.Methods 120 cases with pelvic inflammatory disease were randomly divided into two groups.The control group(60 cases) received intravenous drugs.The observation group(60 cases) were given pelvic infusion therapy.The treatment efficacy of the two groups was compared after treatment for 14 days.Results The obvious effective rate of the observation group was 80.00％,which was significantly higher than 50.00％ in the control group(x2 =11.58,P ＜ 0.05).The total effective rate in the observation group was 90.00％,which was significantly higher than 68.33％ in the the control group(x2 =13.72,P ＜ 0.05).The incidence rate of adverse reactions in the control group was 38.33％,that in the observation group was 20.00％,the difference between the two groups was significant(x2 =4.18,P ＜ 0.05).Conclusion Pelvic perfusion therapy can improve the clinical efficacy of pelvic inflammatory disease,improve the symptoms of patients,reduce side effects,which is worthy of clinical application. More相关知识 - 浏览0 - 被引3 - 下载0 相似文献 - 中文期刊 - 外文期刊 - 学位论文 - 会议论文

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK